Skip to content
Home/Companies/Biotech/Cytos Biotechnology AG

Cytos Biotechnology AG

Biotech·Switzerland·Exited 2002·Held 3yr
Entry
1999
Hold
3yr
Exit
2002

Who owns Cytos Biotechnology AG?

Cytos Biotechnology AG was owned by HealthCap through HealthCap (early funds) (1996 vintage) from 1999 to 2002, exited via IPO.

Hand-verified · updated 2026-08-18

HealthCap
Investor
HealthCap
HealthCap (early funds) · 1996 · VC

Key facts

HQSwitzerland
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2002

More from HealthCap (early funds)

Other portfolio companies in the same fund.

Affibody AB
Active
BiotechSweden· 2001
Pharmion Corp.
Exited 2003
PharmaUS· 2001
Gyros AB
Exited 2016
MedTechSweden· 2000
to
Actelion Holding Ltd
Exited 2017
PharmaSwitzerland· 1997
to
Biotage AB (Pyrosequencing AB)
Exited 2000
BiotechSweden· 1997
Carmeda AB
Exited 2005
MedTechSweden· 1996
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Cytos Biotechnology AG

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Cytos Biotechnology AG?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Cytos Biotechnology AG.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue